Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 65 years old
- People who have been diagnosed with fibromyalgia (based on the Wolfe et al. 2011 research criteria) for at least one year
- People who have been on a stable dose of their current medications and agree not to change their medications, doses, or complementary/alternative treatments during the trial
- People whose average pain level is at least 4 out of 10, and who experience pain on at least half of all days
- People who are able to give written consent and are fluent in English
Who may not be able to join:
- People who have another acute (sudden or short-term) pain condition at the same time
- People who have another ongoing pain condition that they find more painful than their fibromyalgia
- People who take stimulant medications for fatigue related to sleep apnea or shift work (for example, modafinil)
- People who are pregnant or breastfeeding
- People who have a history of a psychiatric condition involving psychosis, such as schizophrenia or severe personality disorders
- People who have a history of anxiety disorders, or anxiety symptoms severe enough to interfere with MRI scanning procedures (for example, panic attacks)
- People who cannot have an MRI scan for medical reasons, such as having metal implants in their body
- People who have had a significant head injury, for example one that caused a substantial period of unconsciousness
- People who have been hospitalised for a psychiatric reason in the past 6 months
- People currently taking part in another treatment-based clinical trial
- People who are currently experiencing active thoughts of suicide
- People who have a diagnosed nerve damage condition with a known cause, such as diabetic nerve damage, chemotherapy-related nerve damage, or Guillain-Barré syndrome
- People who regularly or daily use narcotic medications or substances of abuse
- People who have an autoimmune or inflammatory disease that causes pain, such as rheumatoid arthritis, lupus, or inflammatory bowel disease
- People who have had lower limb vascular (blood vessel) surgery or who currently have a blood vessel problem in their lower limbs
- People whose situation, behaviour, or any other factor leads the study coordinator or principal investigator to believe they would not be able to complete the study, including providing inconsistent or unreliable pain scores (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jeungchan Lee, PhD, Spaulding Rehabilitation Hospital
Phone: 617-952-6742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in brain activity in pain-associated regions such as vPCC/RSC
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.